Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Ethiopia

New Name, Big Ambitions, Significant Challenges

November 2007 | Company News Alert

Ethiopia's rebranded drugmaker Rx For Africa is looking to take on local rival Almeta Impex, which stole the headlines by opening a new ETB90mn (US$10mn) production plant in a joint venture (JV) with India's Cadila Pharmaceuticals in September. The company is pinning its hopes on an aggressive expansion strategy to turn around its flagging

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
MSF Withdraws Medical Services

Industry / Ethiopia According to CISA, medical charity, MSF Switzerland, is halting services in the Fiiq region of Ethiopia due to government obstruction.
July 2008
Indian-Backed Manufacturing Plant Opens

Companies / Ethiopia A joint venture between India's Cadila Pharmaceuticals and Ethiopian firm Almeta Impex has led to the opening of a new ETB90mn (US$10mn) production facility, which will substantially increase Ethiopia's...
September 2007
Roche Extends Helping Hand To African Drug Sector

Companies / Switzerland Swiss drugmaker Roche has announced two technology transfer agreements with African firms, which will help the local manufacture of anti-retroviral (ARV) drugs. Zimbabwe's Varichem Pharmaceuticals...
June 2007
ARV Uptake On The Rise In Africa

Companies / United States The provision of HIV/AIDS drugs in Sub-Saharan Africa has improved markedly in the past year according to a United Nations report. Entitled 'Towards universal access - scaling up priority HIV and AIDS...
April 2007
M&A Strong Last Year

Companies It was an interesting year for M&A in 2006, with the total value of deals rising around 25% to US$3.6bn, as pharmaceutical companies around the world increasingly jostled for position. However, the...
January 2007
Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS